Cervical screening in Australia 2013–2014, Table of contents - Australian Institute of Health and Welfare

Publication
Release Date: 03 May 2016
Author: AIHW
Media release

PDF Report (1.5Mb)

Enter the email address where you would like the PDF sent. This address will not be used for any other purpose.

Newer release available

Cervical screening in Australia 2013–2014 presents the latest national statistics monitoring the National Cervical Screening Program, which aims to reduce incidence, morbidity and mortality from cervical cancer.

ISSN: 2205-4855 (PDF) 1039-3307 (Print)
ISBN: 978-1-74249-927-7
Cat. no: CAN 95
Pages: 105

Findings from this report:

High-grade abnormality detection rates are highest in women 25–29, with rates in those 24 and under at historic lows
It is estimated that 163 women aged 20–69 will die from cervical cancer in 2016
In 2013–2014, more than 3.8 million women participated in cervical screening. This was 57% of women aged 20–69
12% of women with a negative Pap test in 2013 rescreened earlier than the recommended 2 years

Preliminary material
- Title and verso pages
- Contents
- Acknowledgments
- Abbreviations
- Summary
  - Cervical cancer cases and deaths are low by international standards
  - Around 6 in 10 women participate in the National Cervical Screening Program
  - Relatively few women rescreen early, and a third respond to a reminder letter
  - High-grade abnormality detection rates similar, despite decreases in ages <25
- Report card
- Navigating changes in this report
Body section
- 1 Introduction
  - 1.1 Cervical cancer
  - 1.2 The primary cause of cervical cancer is HPV
  - 1.3 Cervical cancer is a largely preventable disease
- 2 The current state of cervical screening in Australia: on the cusp of change
- 3 Monitoring cervical screening in Australia using NCSP data
  - 3.1 Screening behaviour
  - 3.2 Characteristics of the screening test
  - 3.3 Detection of high-grade abnormalities
- 4 Monitoring cervical screening in Australia using AIHW data
  - 4.1 Incidence of cervical cancer
  - 4.2 Survival after a diagnosis of cervical cancer
  - 4.3 Prevalence of cervical cancer
  - 4.4 Mortality from cervical cancer
- 5 Monitoring other aspects of cervical screening in Australia
  - 5.1 Monitoring the safety of cervical screening management guidelines
  - 5.2 Expenditure on cervical screening
End matter
- Appendixes
  - Appendix A: Supporting data tables
    - A1 Participation
    - A2 Rescreening
    - A3 Cytology
    - A4 Histology
    - A5 Cytology-histology correlation
    - A6 Incidence of cervical cancer
    - A7 Mortality from cervical cancer
  - Appendix B: National Cervical Screening Program information
    - Performance indicators
    - Standards
  - Appendix C: Data sources
    - State and territory cervical screening registers
    - AIHW Australian Cancer Database
    - AIHW National Mortality Database
    - ABS Population data
    - AIHW National Hospital Morbidity Database
    - AIHW Disease Expenditure Database
    - Medicare Australia Statistics
  - Appendix D: Data quality statement
    - Data Quality Statement: cervical screening data 2013-2014
  - Appendix E: Classifications
    - Age
    - State or territory
    - Remoteness area
    - Socioeconomic group
    - Classification of cervical cancer by histology
  - Appendix F: Statistical methods
    - Crude rates
    - Age-specific rates
    - Age-standardised rates
- Glossary
- References
- List of tables
- List of figures
- List of boxes
- Related publications
- Supplementary online data tables

Find reports & statistics by topic

Featured reports

Featured

Cervical screening in Australia 2013–2014

Table of contents

AIHW

Feedback